MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

August 18, 2020 08:46:49

MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) brings a pharmaceutical perspective to the cannabis industry, working to internationally recognized pharma-quality standards which result in products that are pure, trusted and precisely doseable for patients and end consumers. MediPharm Labs specializes in the creation and formulation of bulk active pharmaceutical ingredients (API’s) as well as the sale of white-labeled formulated finished products to a wide range of corporate partners in addition to its own proprietary, MediPharm Labs-branded products. MediPharm is currently working on the production of 60 different products and supplying API’s to clients in Australia, Europe, North America as well as the Asia-Pacific region.

Keith Strachan, President and Co-Founder at MediPharm Labs, will be participating in a Fireside Chat together with Tony Noto, Cannabis Editor at Benzinga.

To learn more about MediPharm Labs, visit

For registration information and further details on Benzinga’s Cannabis Capital Conference, visit

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, covers dozens of investor conferences and online events as part of its ongoing service to the investment community. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN utilizes social media and syndicated articles to maximize the visibility of each featured session.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its many event collaborations in 2020, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorBrandNetwork (IBN)
Los Angeles, California
310.299.1717 Office